Know Labs Invents New Way to Detect Blood Glucose – Non-invasively

Know Labs, Inc. (f/k/a Visualant, Incorporated) (OTCQB: KNWN) – a
provider of identification, authentication and diagnostic solutions,
released today a video of the Company’s invention of a new technology to
detect blood glucose non-invasively. In the video, Company CEO Phil
Bosua briefly discusses the breakthrough.

The transcript of Phil Bosua’s narrative in the video states in part:

“We’re developing a brand-new technology platform that measures blood
glucose – non-invasively. Our bench tests are proving to be better than
expected and we’re really excited about the future.”

Link to video:

About Know Labs, Inc.

Know Labs, Inc. (f/k/a Visualant Incorporated) is a public company whose
shares currently trade under the stock symbol “KNWN.” The company’s
technology directs structured light or radio waves through a substance
or material to capture a unique molecular signature. The Company refers
to these signatures as ChromaID™ and Bio-RFID™. ChromaID and Bio-RFID
are used to identify, detect, or diagnose substance markers or
biomarkers that may be invisible to the human eye. ChromaID and Bio-RFID
scanner modules can be integrated into a variety of wearable, mobile or
bench-top form factors. This patented and patent pending, award-winning
technology makes it possible to effectively conduct analyses that could
only previously be performed by invasive and/or large and expensive
lab-based tests. For more information on Know Labs, visit the company’s
website at

This video at the link above and this release contains statements that
constitute forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These statements appear in
a number of places in this release and include all statements that are
not statements of historical fact regarding the intent, belief or
current expectations of Know Labs, Inc., its directors or its officers
with respect to, among other things: (i) financing plans; (ii) trends
affecting its financial condition or results of operations; (iii) growth
strategy and operating strategy. The words may, would, will, expect,
estimate, can, believe, potential and similar expressions and variations
thereof are intended to identify forward-looking statements. Investors
are cautioned that any such forward-looking statements are not
guarantees of future performance and involve risks and uncertainties,
many of which are beyond Know Labs, Inc.’s ability to control, and
actual results may differ materially from those projected in the
forward-looking statements as a result of various factors.

View source version on

Leave a Comment